JWH-185 is a synthetic cannabinoid receptor ligand from the naphthoylindole family. It is the carbonyl-reduced derivative of related compound JWH-081. The binding affinity of JWH-185 for the CB1 receptor is reported as Ki = 17 ± 3 nM.[1]

JWH-185
Legal status
Legal status
Identifiers
  • 3-[(4-Methoxy-1-naphthalenyl)methyl]-1-pentyl-1H-indole
CAS Number
ChemSpider
UNII
Chemical and physical data
FormulaC25H27NO
Molar mass357.497 g·mol−1
3D model (JSmol)
  • CCCCCn1cc(c2c1cccc2)Cc3ccc(c4c3cccc4)OC
  • InChI=1S/C25H27NO/c1-3-4-9-16-26-18-20(22-11-7-8-13-24(22)26)17-19-14-15-25(27-2)23-12-6-5-10-21(19)23/h5-8,10-15,18H,3-4,9,16-17H2,1-2H3
  • Key:OTYBPWBZUDBUQS-UHFFFAOYSA-N

In the United States, all CB1 receptor agonists of the 3-(1-naphthylmethane)indole class such as JWH-185 are Schedule I Controlled Substances.[2]

See also

edit

References

edit
  1. ^ Huffman JW, Mabon R, Wu MJ, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR (2003). "3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor". Bioorg. Med. Chem. 11 (4): 539–549. doi:10.1016/s0968-0896(02)00451-0. PMID 12538019. S2CID 29107765.
  2. ^ 21 U.S.C. § 812: Schedules of controlled substances